EU health regulator says the benefits of the AstraZeneca vaccine outweigh the risks, finding that the vaccine’s side effects like blood clots are “very rare”
EU regulator finds AstraZeneca blood clots “very rare”
You may also like
Whatfinger’s Unfiltered Guide to the Top 64 Fantasy Novels
Our not so daily newsletter. More like weekly…
